We kept most of our Owner Summit sessions short and sweet, but some of our Saturday topics were too meaty to cover in 30 minutes. Here’s a quick roundup of three sessions. read more →
Thanks to Pharmacists Mutual Insurance Company, the Pharmacy Compounding Foundation is offering up to two $2,500 scholarships to pharmacy students who have demonstrated commitment to a career in compounding pharmacy in the US. read more →
Last week in a special edition of Compounding Connections, we shared a handful of new information and practice resources approved by the APC Board of Directors. It’s important for you to be aware of them, so we’re sharing again. read more →
Me again, asking you for money. I do this a lot – too much, really – but the alternative is an underfunded APC that can’t protect your job, pharmacy, and patients. So I’ve got a deal for you. read more →
APC’s Board this week approved minor revisions to its policy statement on Constructive Transfer of compounded controlled substance drugs. The statement was first adopted in 2010. read more →
APC is releasing to its Pharmacy/Facility Members this week a Primer on Compounding Accreditations to assist them in determining accreditations they may wish to pursue. read more →
The voice for pharmacy compounding | March 25, 2022
THIS EDITION SPONSORED BY PCCA
Take charge of your future and the future of compounding at the 2022 ACT Virtual Legislative Conference, May 10 & 12 — your opportunity to meet with federal lawmakers to communicate concerns about patient access to compounded medications. We’ll match you with your representatives and handle all the logistics. Register by March 31 and you could win FREE ACT registration!
From APC’s President
An affair to remember
David J. Miller, RPh APC President
I am having a love affair.
It started 15 years ago. I met a nurse and she said, “You don’t remember me, do you?” I had to admit, I didn’t.
“We met six months ago and you were amazing,” she said … and then proceeded to tell me all about it.
Before you all run and tell my wife, it’s not what you think.
She was a hospice nurse. She had come to me six months prior with a 76-year-old female patient who had sores on her back and could not lay down because it was too painful. She was literally sleeping half standing, slumped over a chair. She was only receiving two hours of sleep at a time and was miserable. The nurse asked me if I could help.
I sprung into action and recommended a pretty simple ketamine/lidocaine/morphine spray that the patient could use to ease her pain. When the nurse returned six months later, she told me her patient has passed — but she passed pain free and had been sleeping in her bed six hours at a time.
Hence began my passion for and love affair with compounding pharmacy — the same love affair I hope all of you have.
That is the reason we are APC members.
If you remember nothing else from my year as APC president, remember this: APC is focused on your success and the success of your industry. I hope you feel that APC is more than just another membership, or just another dues payment. I want you to realize the value APC brings you every day.
Your membership is an investment. Your support of the Campaign to Save Compounded Hormones is an investment. Your contributions to CompPAC are an investment. And all of them pay handsome returns.
It’s not hyperbole to say that, without APC, your ability to compound would be severely limited, and your profession and the ability to do what you love would be crippled.
Would you join me in making one call this week to a passionate compounder and ask them to join APC or enrolling one of your technicians? Ask them to make the same investment in their profession that you have made? Ask them to fuel their love affair?
David Miller is APC’s president and the managing co-owner of Keystone Compounding Pharmacy in Grand Rapids, Michigan. You can reach him at drdave@keystonepharm.com.
This Week
Medisca to match new contributions to save cBHT
Let’s keep the ball rolling in the Campaign to Save Compounded Hormones! How’s this: Through the month of April, Medisca will match every new contribution (not recurring ones) dollar-for-dollar up to $100,000.
That means your support from now through April 30 is doubled thanks to Medisca!
Help us reach our goal of raising $850,000 in 2022 to fund more awareness advertising, more practitioner engagement, an expanded Compounding.com, and new media opportunities. (Click here to see our plans.)
With FDA making clear it intends to use that debunked NASEM report in its decision-making, the fight is more important than ever!
Owner Summit opens in Scottsdale
APC’s second annual Owner Summit opened today, with more than 100 attendees from around the country descending on the Hilton Scottsdale Resort for two intense days of owners-only sessions and networking.
A few pics from day one:
A full house awaits the first session (click to embiggenify)
Michael Blaire and congressional candidate (and APC member) Rich Moon at the Thursday night reception
Allison Linney delivers the Friday-morning keynote (click to enlarginate)
Jason Dunn joins APC as director of business development
Longtime healthcare sales and marketing expert Jason Dunn has joined APC — he’ll take the reins as the new director of business development. That means he’ll be leading the drive to expand APC’s relationships with patrons, affinity partners, and other organizations serving the compounding market.
His first order of business will be putting the new Pharmacy/Facility Membership program into high gear. He’s got the chops — Jason comes to us from Letco’s Fourth Power Labs, where he served as director of business development; before that he was VP of business development for Encore Scientific. He even founded his own company in 2015 — Triova Pharmaceuticals, a wholesale pharmaceutical ingredients supplier in Tulsa, Okla.
Chances are you’ll be hearing from Jason soon enough. We hope you’ll give him a warm welcome!
Be ready to talk the thyroid talk with a free CE webinar
Whether it’s dosage limits, allergies, or other issues, commercial thyroid products simply don’t work for every patient. Learn how — and why — to start the conversation with prescribers about compounded thyroid.
Remdesivir — the 800-pound gorilla of Covid-19 treatments — may soon be available in pill form. Scientists at UNC-Chapel Hill are testing it right now, and it’s looking to be as effective as molnupiravir (already a pill) … at least for mice.
Check it out: RxInsider’s “20Ways” spring retail edition” is now available, with a focus on pharmacy management software. (Be sure to flip to page 79.)
September 14–15, 2022 — APC’s Compounders on Capitol Hill 2022, Hilton National Mall, Washington, DC
APC is committed to addressing any concerns or complaints within one business day. Please send them — and, of course, any compliments — to info@a4pc.org.
